BioSyent, Inc. (RX.V)
15.50
-0.20
(-1.27%)
CAD |
TSXV |
Aug 24, 16:00
BioSyent Profit Margin (Quarterly) : 14.34% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.34% |
| March 31, 2026 | 16.86% |
| December 31, 2025 | 20.59% |
| September 30, 2025 | 21.95% |
| June 30, 2025 | 19.83% |
| March 31, 2025 | 21.13% |
| December 31, 2024 | 18.34% |
| September 30, 2024 | 24.15% |
| June 30, 2024 | 17.67% |
| March 31, 2024 | 22.87% |
| December 31, 2023 | 17.54% |
| September 30, 2023 | 26.50% |
| June 30, 2023 | 18.63% |
| March 31, 2023 | 18.13% |
| December 31, 2022 | 16.08% |
| September 30, 2022 | 21.40% |
| June 30, 2022 | 18.36% |
| March 31, 2022 | 22.56% |
| December 31, 2021 | 26.01% |
| September 30, 2021 | 25.73% |
| June 30, 2021 | 13.97% |
| March 31, 2021 | 22.43% |
| December 31, 2020 | 11.63% |
| September 30, 2020 | 16.56% |
| June 30, 2020 | 15.14% |
| Date | Value |
|---|---|
| March 31, 2020 | 23.94% |
| December 31, 2019 | 20.97% |
| September 30, 2019 | 24.64% |
| June 30, 2019 | 13.40% |
| March 31, 2019 | 21.84% |
| December 31, 2018 | 28.28% |
| September 30, 2018 | 24.16% |
| June 30, 2018 | 27.42% |
| March 31, 2018 | 25.70% |
| December 31, 2017 | 24.69% |
| September 30, 2017 | 23.96% |
| June 30, 2017 | 27.55% |
| March 31, 2017 | 23.59% |
| December 31, 2016 | 21.85% |
| September 30, 2016 | 26.17% |
| June 30, 2016 | 23.22% |
| March 31, 2016 | 25.23% |
| December 31, 2015 | 19.85% |
| September 30, 2015 | 25.58% |
| June 30, 2015 | 23.68% |
| March 31, 2015 | 29.12% |
| December 31, 2014 | 24.63% |
| September 30, 2014 | 27.55% |
| June 30, 2014 | 28.93% |
| March 31, 2014 | 20.89% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -6.95% |
| Bausch Health Cos., Inc. | 9.12% |
| Cipher Pharmaceuticals, Inc. | 33.26% |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | -2.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.52% |
| Return on Assets | 18.71% |
| Return on Invested Capital | 22.34% |
| Gross Profit Margin (Quarterly) | 65.02% |
| Operating Margin (Quarterly) | 19.78% |
| Return on Net Operating Assets | 35.58% |